June 21, 2017
A C.R. Bard Inc. investor filed a proposed class action in New Jersey federal court Wednesday aiming to block the medical supply company's sale to Becton Dickinson and Co., claiming the $24 billion price tag is too low and that investors haven't been given enough information to evaluate the deal.